A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata

NCT05205070 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

BIOLOGICAL: Rosnilimab
BIOLOGICAL: Placebo

Sponsor

AnaptysBio, Inc.